Rajiv Khosla
Directeur Général chez Enteris BioPharma, Inc.
Profil
Rajiv Khosla currently works at Enteris BioPharma, Inc., as Chief Executive Officer.
Dr. Khosla also formerly worked at IntelGenx Technologies Corp., as President, Chief Executive Officer & Director from 2013 to 2014, Orasi Medical, Inc., as President, Chief Executive Officer & Director from 2011 to 2012, Sensient Technologies Corp., as Vice President & General Manager-Pharmaceutical in 2005, and Intelgenx Corp., as Chief Operating & Scientific Officer from 2013 to 2014.
Dr. Khosla received his Masters Business Admin degree from Henley Business School Ltd.
and undergraduate degree from The University of Nottingham.
Postes actifs de Rajiv Khosla
Sociétés | Poste | Début |
---|---|---|
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Directeur Général | - |
Anciens postes connus de Rajiv Khosla
Sociétés | Poste | Fin |
---|---|---|
INTELGENX TECHNOLOGIES CORP. | Directeur Général | 15/07/2014 |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | President | 18/08/2012 |
SENSIENT TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Directeur Général | - |
Formation de Rajiv Khosla
Henley Business School Ltd. | Masters Business Admin |
The University of Nottingham | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SENSIENT TECHNOLOGIES CORPORATION | Consumer Non-Durables |
INTELGENX TECHNOLOGIES CORP. | Health Technology |
Entreprise privées | 3 |
---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Health Technology |